NinePoint makes ex-NeuroTherm chief CEO
This article was originally published in Clinica
Executive Summary
Organ imaging specialist NinePoint Medical has appointed Christopher von Jako president and CEO. He replaces Charles Carignan, who in July left to head up personal bionics company BiOM. Dr von Jako previously led spinal pain treatment firm NeuroTherm, which was acquired by St Jude Medical for $200m in July. Before this, he was president of minimally-invasive navigation solutions developer ActiViews, and has also worked for Integra LifeSciences, Covidien, Medtronic and Radionics. Cambridge, Massachusetts-based NinePoint has developed the NvisionVLE Imaging System that enables physicians to endoscopically view the esophagus; the information can be used for biopsy or treatment planning. The system was first FDA 510(k)-cleared in 2012, and it is also CE marked in Europe. In March, Ninepoint completed a $34m series B financing, which will support the ongoing launch of NvisionVLE in the US.